Patent · US Active

Culturing circular ssDNA viruses for the production of vaccines

US7566562B2 · kind B2 · utility

1Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2007
Grant dateJul 28, 2009
Priority date
Expiry dateFeb 28, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/10034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of interferon in the in vitro cultivation of animal circular ssDNA virus such as Porcine Circovirus 2 or human TT virus in an animal cell line. Increased titres of animal circular ssDNA virus are obtained by addition of interferons or agents which ensure the production of endogenous interferons by said cell line and/or by the reduction of endosomal-lysosomal system acidification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.